Basic Information
| LncRNA/CircRNA Name | n340790 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | thyroid cancer |
| ICD-0-3 | C73.9 |
| Methods | qPCR, Western blot etc. |
| Sample | thyroid cancer tissues, cell line (SW579) |
| Expression Pattern | up-regulated |
| Function Description | Here, we found that the lncRNA n340790 was highly expressed in human thyroid cancer tissues and was strongly correlated with the clinical characteristics of patients. There was a good prognostic value of n340790 for thyroid cancer. Furthermore, we discovered that n340790 could act as an endogenous sponge by directly binding to miR-1254 and downregulating miR-1254 expression. |
| Pubmed ID | 28559970 |
| Year | 2017 |
| Title | The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254 |
External Links
| Links for n340790 | GenBank HGNC NONCODE |
| Links for thyroid cancer | OMIM COSMIC |